TATUM MARTINO: Open Payments
NPI 1457847998 · WARREN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 30 payments from 11 companies in 2025. Trend: 2023 $709 · 2024 $808 · 2025 $726
Food & beverage: $641Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $206 |
| Janssen Biotech, Inc. | 6 | $153 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| Galderma Laboratories, L.P. | 4 | $74 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $72 |
| Incyte Corporation | 2 | $40 |
| GENZYME CORPORATION | 1 | $30 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Organon LLC | 2 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: TREMFYA, RINVOQ, DUPIXENT, NEMLUVIO, Cabtreo, SKYRIZI, OPZELURA, Winlevi.
Industry payments across OH — which companies pay providers there.
